Strategic Pricing and Contract Re-negotiations in Commercial Services
ABM actively engaged in re-negotiating long-term contracts with marquee clients in pressured markets, often at slightly lower margins to secure extensions.
The company strategically lowered bid thresholds by approximately 100 basis points in high-growth sectors like semiconductor and pharma to win new business.
These contract re-negotiations are designed to extend client relationships for 3-5 years, with the expectation of margin recovery over time.
Scott emphasized that these pricing strategies are part of a long-term relationship-building approach, not just short-term margin sacrifices.
Adjusted diluted EPS rose 13% to $0.87 from $0.77 in the prior year, reflecting higher net income and share repurchases.
Adjusted EBITDA increased 4% to $266 million, but adjusted EBITDA margin declined 40 basis points to 12.7% due to higher SG&A as a percentage of sales.
Gross margin improved to 26.8%, up 10 basis points sequentially and 40 basis points year over year, driven by private label and sourcing initiatives.
Net debt stood at $2.3 billion with a leverage ratio of 2.4x, and total liquidity was $1.1 billion.
Net sales grew nearly 7% to $2.1 billion in Q2 2025, with approximately 5% organic growth and the remainder from acquisitions.
Operating cash flow was $34 million, down from $48 million last year, mainly due to higher working capital investment.
SG&A expenses increased 13% to $302 million, impacted by acquisitions, inflation, and one-time costs.
Strategic Portfolio Review and Focus on Core Markets
Amcor completed a strategic review of its portfolio, focusing on defining its core markets in consumer packaging and identifying businesses less aligned with these priorities.
The company identified approximately $2.5 billion in sales from businesses that are less aligned with its core portfolio, which will be explored for value maximization through restructuring, partnerships, or sales.
Amcor is emphasizing growth in attractive nutrition and health markets, leveraging its leadership positions and technological capabilities.
The portfolio review aims to enhance focus, drive more consistent organic growth, and create shareholder value by divesting or restructuring non-core assets.
The process of portfolio optimization is ongoing, with no fixed timeline, but some smaller assets are expected to be addressed in fiscal 2026.